Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Arch Dermatol Res ; 307(9): 757-66, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26048131

RESUMO

Determined efficacies of benzoyl peroxide may be affected by study design, implementation, and vehicle effects. We sought to elucidate areas that may allow improvement in determining accurate treatment efficacies by determining rates of active treatment and vehicle responders in randomized controlled trials assessing the efficacy of topical benzoyl peroxide to treat acne. We conducted a systematic review of randomized vehicle-controlled trials evaluating the efficacy of topical benzoyl peroxide for the treatment of acne. We compared response rates of vehicle treatment arms versus those in benzoyl peroxide arms. Twelve trials met inclusion criteria with 2818 patients receiving benzoyl peroxide monotherapy treatment and 2004 receiving vehicle treatment. The average percent reduction in total number of acne lesions was 44.3 (SD = 9.2) and 27.8 (SD = 21.0) for the active and vehicle treatment groups, respectively. The average reduction in non-inflammatory lesions was 41.5 % (SD = 9.4) in the active treatment group and 27.0 % (SD = 20.9) in the vehicle group. The average percent decrease in inflammatory lesions was 52.1 (SD = 10.4) in the benzoyl peroxide group and 34.7 (SD = 22.7) in the vehicle group. The average percentage of participants achieving success per designated study outcomes was 28.6 (SD = 17.3) and 15.2 (SD = 9.5) in the active treatment and vehicle groups, respectively. Patient responses in randomized controlled trials evaluating topical acne therapies may be affected by clinical trial design, implementation, the biologic effects of vehicles, and natural disease progression. "No treatment" groups may facilitate determination of accurate treatment efficacies.


Assuntos
Acne Vulgar/tratamento farmacológico , Peróxido de Benzoíla/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Projetos de Pesquisa , Administração Tópica , Antibacterianos/uso terapêutico , Géis/uso terapêutico , Humanos , Efeito Placebo , Propionibacterium acnes/efeitos dos fármacos , Resultado do Tratamento
4.
Food Chem Toxicol ; 66: 1-6, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24440561

RESUMO

This in vitro investigation evaluated [(14)C] - d-methamphetamine hydrochloride ([(14)C]-meth HCl) transfer from contaminated vinyl tile (non-porous and smooth) and upholstery fabric (rough and loose) to human skin. (14)C-Meth HCl transfer rate from vinyl to skin was rapid; a contact duration as brief as 15s resulted in measurable radioactivity in the skin and receptor fluid samples. In contrast, the transfer from fabric occurred more slowly: the amount of [(14)C]-meth HCl that was transferred from dry fabric after 2-h skin contact was one-fifth the amount transferred from vinyl after 5-min contact time. With moistened fabric, the transfer efficiency to skin after 2-h contact was seven times greater than that of dry fabric. While the duration of surface-skin contact appeared to affect the total dermal absorption of [(14)C]-meth HCl, it had little effect on the time point of maximum transdermal absorption. [(14)C]-meth HCl retained in skin continued to be absorbed after the contaminated material was removed. Mass balance in these studies was approximately 96%. In conclusion, [(14)C]-meth HCl penetrates into/through human skin quickly following skin contact with contaminated materials. The porosity of the contact surface and the moisture content appears to alter the degree of transfer and dermal penetration.


Assuntos
Metanfetamina/toxicidade , Características de Residência , Pele/efeitos dos fármacos , Humanos , Metanfetamina/farmacocinética
8.
Wound Repair Regen ; 21(6): 789-92, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24134696

RESUMO

Chronic cutaneous wounds are a major burden on patients, healthcare providers, and the US healthcare system. This study, carried out in part by the Wound Healing Society's Government Regulatory Committee, aimed to evaluate the current state of National Institutes of Health funding of cutaneous wound healing-related research projects. National Institutes of Health Research Portfolio Online Reporting Tools Expenditures & Results system was used to identify wound healing projects funded by the National Institutes of Health in the 2012 fiscal year. Research projects focusing on cutaneous wound prevention/education, mechanisms, complications, treatment, or imaging/monitoring were included in the analysis. Ninety-one projects were identified, totaling a collective funding of $29,798,991 and median funding of $308,941. Thirteen institutes/centers from the National Institutes of Health were responsible for awarding funds; three of which (National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases) accounted for 60.4% of the grant funding. The predominant funding mechanisms included R01 (48.3%), R43 (14.3%), and R21 (9.9%). New applications and pre-existing applications accounted for 39.6 and 55.0% of the awarded grants, respectively. Grants awarded to investigators affiliated with universities accounted for 68.1% of grants and 25.3% were to investigators in the private sector. This analysis of current National Institutes of Health funding may facilitate more transparency of National Institutes of Health-allocated research funds and serve as an impetus to procure additional support for the field of wound healing.


Assuntos
Pesquisa Biomédica/economia , Financiamento Governamental , Apoio à Pesquisa como Assunto , Cicatrização , Doença Crônica , Feminino , Financiamento Governamental/economia , Financiamento Governamental/estatística & dados numéricos , Humanos , Masculino , National Institutes of Health (U.S.)/economia , Estados Unidos
9.
Cutan Ocul Toxicol ; 32(1): 67-71, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22667459

RESUMO

CONTEXT: Despite new technologies, few studies have quantified changes in melanocyte numbers associated with postinflammatory hyperpigmentation (PIH) secondary to exogenous causes. OBJECTIVE: This article aims to review what is known about the pathogenesis of PIH secondary to external insults and its relationship to the resultant degree of quantitative changes in melanocytes. METHODS: We performed a review of articles exploring PIH resulting from external cutaneous insults retrieved through database searching. We reviewed relevant articles for the pathogenesis, histopathology, and quantitative changes in melanocytes related to specific etiologies of PIH. Methodologies to quantify pigmentation changes in dermatologic conditions with clinical hyperpigmentation were also explored. RESULTS: Significant increases in melanocyte counts of irritant affected skin is seen compared with melanocyte counts of unaffected skin. An increase in melanocyte counts was also found for spontaneous inflammatory dermatoses, even in the absence of clinical hyperpigmentation. Furthermore, changes in melanocyte density and appearance are also seen secondary to inflammation. In addition, increases in epidermal melanocytes are seen with cutaneous exposure to certain agents, and melanocyte increases vary by exposure agent. CONCLUSIONS: The degree of hyperpigmentation related to the intensity and duration of exposure to the causative factors of PIH is essential to better understand the pathophysiology of the disease process. The application of new methodologies to determine quantitative changes in melanocytes elicited by specific causative inflammatory agents has implications to prevent PIH, add to knowledge about disease duration, to develop better treatments for PIH, and to aid our understanding of the biology of the melanocyte.


Assuntos
Hiperpigmentação/etiologia , Animais , Humanos , Hiperpigmentação/diagnóstico , Hiperpigmentação/epidemiologia , Hiperpigmentação/metabolismo , Inflamação/complicações , Melaninas/metabolismo , Pigmentação da Pele/fisiologia
10.
J Appl Toxicol ; 33(3): 157-72, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23112046

RESUMO

Since the advent of World War II, governments and laboratories have made a concerted effort to improve prophylactic and therapeutic interventions counteracting cutaneously directed chemical warfare agents (CWA), and by inference, common industrial and consumer dermatotoxicants. In vitro percutaneous penetration assays, first utilized by Tregear in the 1940s and presently in various modifications, have been fundamental to this effort. Percutaneous penetration, often considered a simple one-step diffusion process, consists of at least 15 steps. The first part of this review covers the initial steps related to absorption and excretion kinetics, vehicle characteristics, and tissue disposition. Importantly, the partitioning behavior and stratum corneum (SC) diffusion by a wide physicochemical array of compounds shows that many compounds have similar diffusion coefficients determining their percutaneous absorption in vivo. After accounting for anatomical SC variation, the penetration flux value of a substance depends mainly on its SC/vehicle partition coefficient. Additionally, the SC acts as a 'reservoir' for topically applied molecules and application of tape stripping has been found to quantify the chemical remaining in the SC which can predict total molecular penetration in vivo. Decontamination is of particular concern and even expediting standard washing procedures after dermal chemical exposure often fails to remove chemicals. This overview summarizes knowledge of percutaneous penetration extending insights into the complexities of penetration, decontamination and potential newer assays that may be of practical importance.


Assuntos
Descontaminação/métodos , Modelos Biológicos , Absorção Cutânea/fisiologia , Pele/metabolismo , Xenobióticos/farmacocinética , Animais , Difusão , Humanos , Técnicas In Vitro , Pele/química , Xenobióticos/química
11.
J Appl Toxicol ; 33(3): 173-82, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23112095

RESUMO

Cutaneously directed chemical warfare agents can elicit significant morbidity and mortality. The optimization of prophylactic and therapeutic interventions counteracting these agents is crucial, and the development of decontamination protocols and methodology of post dermal exposure risk assessments would be additionally applicable to common industrial and consumer dermatotoxicants. Percutaneous (PC) penetration is often considered a simple one-step diffusion process but presently consists of at least 15 steps. The systemic exposure to an agent depends on multiple factors and the second part of this review covers absorption and excretion kinetics, wash and rub effects, skin substantivity and transfer, among others. Importantly, the partitioning behavior and diffusion through the stratum corneum (SC) of a wide physicochemical array of compounds shows that many compounds have approximately the same diffusion coefficient which determines their percutaneous absorption in vivo. After accounting for anatomical variation of the SC, the penetration flux value of a substance depends mainly on its SC/vehicle partition coefficient. Additionally, the SC acts as a 'reservoir' for topically applied molecules, and tape stripping methodology can quantify the remaining chemical in the SC which can predict the total molecular penetration in vivo. The determination of ideal decontamination protocols is of utmost importance to reduce morbidity and mortality. However, even expeditious standard washing procedures post dermal chemical exposure often fails to remove chemicals. The second part of this overview continues to review percutaneous penetration extending insights into the complexities of penetration, decontamination and potential newer assays that may be of practical importance.


Assuntos
Descontaminação/métodos , Modelos Biológicos , Absorção Cutânea/fisiologia , Pele/metabolismo , Xenobióticos/farmacocinética , Animais , Difusão , Humanos , Técnicas In Vitro , Pele/efeitos dos fármacos
12.
Drug Dev Ind Pharm ; 39(9): 1401-7, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22873754

RESUMO

This study determined the onychopharmacokinetics, nail absorption, distribution, and penetration of [¹4C]-terbinafine HCl in a new topical formulation into/through the human finger nail using the in vitro finite dose model. This study determined the penetration rate of terbinafine HCl from multiple doses of topical formulation applied daily for 14 days. Results showed that the total dose recovery (mass balance) was almost 100%. The concentration of terbinafine HCl in the deeper nail plate (ventral/intermediate layers) and the cotton-pad nail bed samples after the 14-day treatment were 613 ± 145 and (±S.D.) and 27 ± 1.2 µg/cm³ (or 1.9 ± 0.6 µg/cm³ daily) on average, respectively. In comparison with nail concentration data from the literature for other topical terbinatine formulations, our results show that higher amounts of terbinafine HCl reached the deep nail plate and/or the nail bed after a 14-day topical treatment with this topical formulation in vitro.


Assuntos
Antifúngicos/metabolismo , Unhas/metabolismo , Naftalenos/metabolismo , Absorção , Administração Tópica , Adsorção , Adulto , Antifúngicos/administração & dosagem , Antifúngicos/farmacologia , Radioisótopos de Carbono , Fenômenos Químicos , Humanos , Técnicas In Vitro , Cinética , Testes de Sensibilidade Microbiana , Unhas/química , Unhas/efeitos dos fármacos , Naftalenos/administração & dosagem , Naftalenos/farmacologia , Permeabilidade , Propriedades de Superfície , Terbinafina
13.
Rev Environ Health ; 27(2-3): 85-101, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23109538

RESUMO

Benzene is a widespread, naturally occurring substance of environmental concern as systemic exposure in humans is proven to be carcinogenic. Dermal exposure is a common and significant route of systemic entry and percutaneous absorption is critical in exposure risk assessment. This article reviews the scientific principles, methodologies, and research behind the multiple steps of the percutaneous absorption of benzene in animals and man and the application of this information to optimize exposure risk assessments. A focus on occupational exposures to benzene is made with an exploration of the limitations of current preventative measures and hazard assessments. Finally, recommendations for future research to fill existing knowledge gaps are made.


Assuntos
Benzeno/farmacocinética , Poluentes Ambientais/farmacocinética , Animais , Humanos
14.
Immunotherapy ; 4(9): 939-45, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23046237

RESUMO

Actinic keratoses are common in older individuals and topical immunotherapy is an important treatment when multiple lesions are present. To assess the efficacy of 5-fluorouracil in treating actinic keratoses, a systematic review of randomized, vehicle-controlled trials was performed. Percentages of 5-fluorouracil and vehicle responders were determined by absolute clearance and mean percent reduction in lesion count. Four trials with 399 and 269 participants in active treatment and vehicle groups, respectively, were evaluated. After 4 weeks of treatment, total clearance and mean lesion count reduction were 52.6 and 90.2% in the treatment group versus 0.85 and 28.3% in the vehicle group, respectively. Topical 5-fluorouracil is efficacious in treating actinic keratoses; however, vehicle responses warrant further investigation of study design and disease severity scales.


Assuntos
Fluoruracila/administração & dosagem , Ceratose Actínica/tratamento farmacológico , Administração Tópica , Feminino , Humanos , Ceratose Actínica/etiologia , Masculino , Pessoa de Meia-Idade , Veículos Farmacêuticos , Ensaios Clínicos Controlados Aleatórios como Assunto
15.
Food Chem Toxicol ; 50(12): 4436-40, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22902806

RESUMO

This study evaluated pH effects on [(14)C] d-methamphetamine hydrochloride ([(14)C]-meth HCl) percutaneous penetration in vitro and volatility and stability in aqueous solution, on solid surface, or human skin using the finite dose technique and flow through diffusion cells. Results show that when the pH level exceeds 4 or 5, the nonvolatile [(14)C]-meth HCl salt becomes unstable, likely converting to its volatile freebase form. Additionally, contaminated smooth, dense surfaces retain and transfer more [(14)C]-meth HCl than those with rough, loose surfaces, especially under acidic conditions. Skin surface pH is a critical factor affecting the rate and magnitude of dermal absorption. [(14)C]-Meth HCl penetrates into and through the human cadaver skin quickly following exposure. [(14)C]-Meth HCl retained in the skin layer is released into the receptor fluid even if the contact material has been removed. Future exploration of decontaminant and removal procedure efficacies and their effect on dermal penetration of [(14)C]-meth HCl is recommended.


Assuntos
Metanfetamina/farmacocinética , Absorção Cutânea , Pele/efeitos dos fármacos , Administração Cutânea , Adolescente , Adulto , Idoso , Difusão , Relação Dose-Resposta a Droga , Exposição Ambiental , Feminino , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Propriedades de Superfície , Volatilização , Adulto Jovem
16.
Arch Dermatol Res ; 304(9): 707-17, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22843024

RESUMO

There is a need to better define how the efficacy of investigational drugs is affected by study design, implementation, and placebo responses in randomized controlled trials. The improvements observed in placebo groups within trials examining psoriasis treatments may be partially due to study design and implementation. We conducted a systematic review of randomized placebo-controlled trials assessing the efficacy of biologics in the treatment of psoriasis and psoriatic arthritis to evaluate rates of placebo and active drug responders to determine specific factors within study design that may contribute to placebo responses. We included randomized, placebo-controlled trials of etanercept, infliximab, adalimumab, golimumab, ustekinumab, alefacept, and efalizumab that utilized Psoriasis Area Severity Index as an outcomes measure. We compared the rates of the placebo treatment arm versus the active drug arm achieving 75 % improvement of Psoriasis Area Severity Index. 31 trials involving 8285 active treatment and 3999 placebo patients were included. Rates of placebo responders (4.14 %) were significantly lower than active drug responders (48.4 %). The overall odds ratio calculated was 23.94 (p < 0.0001, 95 % CI 16.02-35.76). Binomial regression models showed that treatment indication, randomization fraction, a PASI inclusion requirement, and the time period of outcomes measure documentation affect placebo responses. Placebo responses seen in randomized controlled trials evaluating biologics in the treatment of psoriasis are not likely due to a physiologic mechanism, but may be secondary to chronic disease course and factors of clinical trial design and implementation.


Assuntos
Produtos Biológicos/uso terapêutico , Psoríase/tratamento farmacológico , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Artrite Psoriásica/tratamento farmacológico , Humanos , Índice de Gravidade de Doença , Resultado do Tratamento , Fator de Necrose Tumoral alfa/antagonistas & inibidores
17.
J Am Acad Dermatol ; 67(4): 576-81, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22243769

RESUMO

BACKGROUND: With advancements in mobile technology, cellular phone-based store-and-forward teledermatology may be applied to skin cancer screening. OBJECTIVE: We sought to determine diagnostic and management concordance between in-person and teledermatology evaluations for patients at skin cancer screening whose clinical images and history were transmitted through mobile phones. METHODS: A total of 86 patients with 137 skin lesions presented to a skin cancer screening event in California. These patients' clinical history and skin images were captured by a software-enabled mobile phone. Patients were assessed separately by an in-person dermatologist and a teledermatologist, who evaluated the mobile phone-transmitted history and images. Diagnostic and management concordance was determined between the in-person and teledermatology evaluations. RESULTS: The primary categorical diagnostic concordance was 82% between the in-person dermatologist and the teledermatologist (95% confidence interval 0.73-0.89), with a Kappa coefficient of 0.62 indicating good agreement. The aggregated diagnostic concordance between the in-person dermatologist and the teledermatologist was 62% (95% confidence interval 0.51-0.71), with Kappa coefficient of 0.60 indicating good agreement. Management concordance between the in-person dermatologist and the teledermatologist was 81% (95% confidence interval 0.72-0.88), with a Kappa coefficient of 0.57, which indicates moderate agreement between the dermatologists. Multivariate analysis showed that older age and presentation of atypical nevus were significantly associated with disagreement in diagnosis between the teledermatologist and in-person dermatologist, after adjusting for other factors. LIMITATIONS: Dermatoscopic images were not captured via mobile phones, which might improve diagnostic accuracy. CONCLUSION: Mobile teledermatology using cellular phones is an innovative and convenient modality of providing dermatologic consultations for skin cancer screening.


Assuntos
Telefone Celular/instrumentação , Dermatologia/instrumentação , Dermatologia/organização & administração , Neoplasias Cutâneas/diagnóstico , Telemedicina/instrumentação , Telemedicina/organização & administração , Adulto , California , Dermatologia/estatística & dados numéricos , Feminino , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Masculino , Programas de Rastreamento/instrumentação , Programas de Rastreamento/organização & administração , Programas de Rastreamento/estatística & dados numéricos , Pessoa de Meia-Idade , Variações Dependentes do Observador , Lesões Pré-Cancerosas/diagnóstico , Avaliação de Programas e Projetos de Saúde , Software
18.
Arch Dermatol ; 148(1): 61-5, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22250233

RESUMO

OBJECTIVE: To assess the impact of live interactive teledermatology consultations on changes in diagnosis, disease management, and clinical outcomes. DESIGN: We conducted a retrospective analysis of 1500 patients evaluated via live interactive teledermatology between 2003 and 2005 at the University of California, Davis. We compared diagnoses and treatment plans between the referring physicians and the teledermatologists. Patients with 2 or more teledermatology visits within a 1-year period were assessed for changes in clinical outcomes. SETTING: Academic medical center with an established teledermatology program since 1996. PARTICIPANTS: Medical records were evaluated for 1500 patients who underwent live interactive teledermatology consultation. Patients seen for more than 1 teledermatology visit were included in the clinical outcome assessment. INTERVENTION: Live interactive teledermatology consultation. MAIN OUTCOME MEASURES: Changes in diagnosis, disease management, and clinical outcome. RESULTS: Compared with diagnoses and treatment plans from referring physicians, the 1500 live interactive teledermatology consultations resulted in changes in diagnosis in 69.9% of patients and changes in disease management in 97.7% of patients. Among 313 patients with at least 2 teledermatology visits within 1 year, clinical improvement was observed in 68.7% of patients. Multivariate analysis showed that changes in diagnosis (P = .01), changes in disease management (P < .001), and the number of teledermatology visits (P < .001) were significantly associated with improved clinical outcomes. CONCLUSIONS: Live interactive teledermatology consultations result in changes in diagnosis and disease management in most consultations. The numbers of live interactive teledermatology visits and changes in diagnosis and disease management are significantly associated with improved clinical outcomes.


Assuntos
Dermatologia/métodos , Dermatopatias/diagnóstico , Dermatopatias/terapia , Telemedicina/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Gerenciamento Clínico , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA